Chronic Cold Acclimation Stimulates the Browning of Subcutaneous White Adipose in Patients With Type 2 Diabetes Mellitus
NCT ID: NCT02775253
Last Updated: 2016-06-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
11 participants
INTERVENTIONAL
2016-05-31
2016-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diabetes, Insulin Resistance and Body Composition
NCT06724068
Study of Biomarkers in Diabetic Chronic Wounds
NCT05342740
Impact of Muscle and Tendon Dysfunction in People With Type 2 Diabetes Mellitus
NCT05585502
Chronic Wound Care of Lower Limb in M@diCICAT Center at CHU de Martinique
NCT05491291
The Effect of Intensive Multifactorial Therapy on Endothelial Function in Newly Diagnosed Type 2 Diabetes
NCT01101503
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Chronic cold acclimation group
All patients will be conducted a chronic cold acclimation intervention for 33 days.
Chronic cold acclimation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Chronic cold acclimation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18-60 years old
* Body mass index 18.5-28 kg/m2
* HbA1c \< 6.5%
* Well controlled diabetes
Exclusion Criteria
* Body mass index \< 18.5 kg/m2
* Body mass index \> 28 kg/m2
* Female
* Taking any drugs other than metformin
* haemoglobinA1c \>=6.50%
18 Years
60 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Xiang Guang-da
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Xiang Guang-da
Director of Endocrinol Dept.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Wuhan General Hospital
Wuhan, Hubei, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016Wze005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.